We publish a lot of guidance about how to buy cannabis clones, but we rarely turn the lens on our own catalog. This post fixes that. Below is a data study of the Clone Source inventory snapshot taken September 20, 2026: every number here comes straight from our live inventory data, pulled the day before this post was written. No estimates, no marketing rounding.
First, the headline numbers. The catalog held 39 strains. Nineteen of those strains had rooted clones on hand, totaling 714 clones in inventory. The remaining 20 strains were at zero stock in the snapshot, which is normal for a nursery where popular cuts sell through between propagation cycles.
The pricing architecture sorts into five clean tiers. Eleven strains were listed at $50, fourteen at $100, seven at $250, six at $500, and one at $1,000. That top-tier strain is Dante's Wrath, priced as a collector-tier cut, with 54 clones on hand in the snapshot.
Averages can mislead, so here is the median alongside the mean. The average listed price across all 39 strains was about $197, but the median was exactly $100. That gap exists because the $500 and $1,000 tiers pull the mean upward while the middle of the catalog actually sits at the $100 mark. If someone tells you clone shopping is expensive, the mode of this catalog says otherwise: the single most common price was $100.
Stock depth varied sharply by tier, and not the way you might guess. The $50 tier held the most units at 180 clones across five in-stock strains. The $100 tier followed with 159 clones across six strains, the $250 tier with 162 clones across three strains, the $500 tier with 159 across four strains, and the $1,000 tier with 54 on a single strain. Combined, the $50 and $100 tiers carried 339 rooted clones across eleven in-stock strains, which is where a buyer on a budget should look first.
The genetics mix skews modern. Nineteen strains were listed as hybrid, seventeen as indica-dominant, and just three as sativa-dominant. That ratio mirrors where breeding has moved over the past decade: most new commercial crosses are hybrid or indica-leaning, and true sativa-dominant cuts have become the rarity in any catalog, ours included.
Breeder attribution is the one place our data is less complete than we would like. Fifteen strains are listed without a breeder attribution in the catalog. The rest carry named lines: five from Exotic Genetix, four from Beanfiendz, two each from Favrd, Lovin' in Her Eyes, and Simpl Commercial, and singles from Solfire Gardens and SeedJunky. If provenance matters to your program, that field is worth checking on any strain page before ordering.
On testing: all 39 strains in the snapshot were flagged as pathogen-tested in our catalog data. Our screening covers Hop Latent Viroid plus the Fusarium and Pythium fungal pathogens, using PCR testing — a standard we apply across the catalog rather than a per-strain add-on.
Why publish our own numbers? Two reasons. First, transparency: anyone comparing nurseries can hold our catalog up against the claims we make elsewhere on this site. Second, freshness: a dated snapshot is honest in a way that a static 'in stock' badge is not. Inventory at a clone nursery moves daily, and this study shows exactly what that inventory looked like on September 20, 2026.
A few practical takeaways if you are shopping from this data. Budget buyers get the widest selection-plus-depth combination in the $50 to $100 tiers. Growers hunting premium cuts should expect thinner stock in the $250 and $500 tiers, where seven strains in the snapshot accounted for only 321 clones combined. Collector-tier genetics exist but move in small volumes, so they justify checking availability before planning a program around them.
One caveat worth repeating: this is a point-in-time study. Stock counts change as clones sell and new propagation cycles root out. Treat these figures as a transparency snapshot, not a live price list, and confirm current availability on the product page or with us directly before ordering.
We plan to rerun this study periodically and keep the historical snapshots comparable, so over time these posts double as a record of how the catalog has shifted: which tiers carry the depth, how the hybrid-to-sativa ratio drifts, and where new breeder lines land. For now, the September 2026 picture is a catalog of 39 strains, five price tiers, and 714 rooted clones ready to go.
How to Use This Data When You Order
The patterns above are most useful at order time, not in the abstract. Three practical moves:
- Match tier to goal. If your cycle is built around a proven yielder, the value tier does that job at the lowest cost per plant. Reserve the premium tier for canopy positions where visual bag appeal or rare genetics actually drive your margin. - Order in waves. The availability data shows fast movers cycling out within days. Splitting an order between a reliable anchor cultivar and a fresh drop lets you hold the schedule while testing something new without betting the cycle on it. - Buy for the room, not the menu. A cultivar that finished beautifully for someone else in a different light footprint and medium can still disappoint in your room. Catalog data is a starting filter; your own room is the final test.
What We'll Track Next Month
September's study is a snapshot, and snapshots get more useful as a series. Going forward we'll track the same availability and pricing metrics monthly, so shifts become visible: which tiers move fastest as the market absorbs new drops, how intro pricing behaves after a cultivar's first month, and whether seasonal patterns — spring outdoor planning, fall indoor pushes — show up in clone ordering the way they do in seed sales. The goal is a running dataset that turns strain selection from a gut call into a repeatable decision, for us and for anyone using the catalog to plan their next cycle.
